Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
about
Key mechanisms governing resolution of lung inflammationUS Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisHighlight on advances in nontuberculous mycobacterial disease in North America.Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New InsightsAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophagesAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiMultidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imagingPrevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease.Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry.Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisAntimicrobial treatment of non-cystic fibrosis bronchiectasis.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.Cystic fibrosis in Austria.Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician.Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.Data that empower: The success and promise of CF patient registries.Evaluation of a bovine antibody test for diagnosing Mycobacterium avium complex in patients with cystic fibrosis.Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop ReportNontuberculous mycobacteria in diffuse panbronchiolitis.Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases.Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.Nontuberculous Mycobacteria in Cystic Fibrosis.
P2860
Q26749606-1FB1CE59-A06C-40E9-9AF4-174C709EE8FCQ26775974-3B31A8C0-6220-4C14-A6C7-6604B5A39FDDQ27028191-E877DCEE-1839-400E-8E5C-047BBDB67613Q28087593-4C2A6949-68B3-4417-BCB7-748EC158E2FEQ30244524-B2B063E0-DBE4-42C0-ACDE-56BA40235E20Q33568014-631A63DF-CB4D-4895-BDA8-2E3B4EF7C856Q33792765-75EB4ECE-3CA7-4AD9-BA11-F23EE6729FBBQ34058548-40C6D785-4F17-4F50-9B91-CF7EC797D487Q34117376-790616A4-64F5-4E24-BF53-2E179E32CEA6Q34419659-1B12B1E5-A62C-4FCE-9E5F-B2EAD6892DE4Q34425805-545D70CD-E5F0-4043-B8C8-DB00F463CAB0Q34982469-6A367CE9-7C5A-4431-8B93-A2109CFE0F3FQ35035791-7CCB8131-881F-4D2D-B226-0D2F956FBFA7Q36213685-ED71552C-D7DF-4D8F-9157-7868BBB8C803Q37679780-E97963E0-F351-48B5-BC77-4CFBF0492215Q38243206-3A2DE46A-70F2-41C8-AD9F-F65CB21796C0Q38749090-56258282-7427-4E34-A76E-F43CBB088689Q38764394-597E41B2-43AB-4848-B43A-28CFA8F7E489Q38943041-ADB3C73E-05E2-411C-8C75-C8D2DF14584CQ39100345-6D64CFD5-3324-4AF2-BD89-89262B27D55FQ39638382-1079B2BD-3EA3-4338-9523-64605DA2FCE1Q40041155-64394B39-D240-4BB7-A1AE-68BAEB7D8C60Q40534009-B937B5DC-BB75-41A6-881E-85F76938C9D9Q40540630-C5E641A1-483E-4555-AF71-88AA56AD1955Q41721189-E41D92CD-6C17-442F-B5B3-5BC4826F0E3EQ41880748-2BE92EB0-60DD-4A09-B10B-189E43A455B7Q47147744-785D4A9D-74E9-4F4D-B344-90A46295D672Q52768051-51378490-0508-412F-91E4-4B959F31547B
P2860
Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@en
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@nl
type
label
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@en
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@nl
prefLabel
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@en
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@nl
P2093
P2860
P1476
Epidemiology of nontuberculous ...... persons with cystic fibrosis.
@en
P2093
Alison M Binder
D Rebecca Prevots
Jennifer Adjemian
Kenneth N Olivier
P2860
P304
P356
10.1164/RCCM.201307-1200OC
P407
P577
2013-10-01T00:00:00Z